Physician profile
Michael S Bohlman
NPI 1386756799
$1,227.15
in general payments reported to CMS, 2019-2025
22 companies · $28.91 in 2025
The $28.91 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $280 · 2021: $367 · 2022: $219 · 2023: $126 · 2024: $13.08 · 2025: $28.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $173.63 | 2019-2023 | Grafix Pl |
| Alnylam Pharmaceuticals INC. | $153.93 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.00 | 2020-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $90.38 | 2020-2022 | |
| Novo Nordisk INC | $83.65 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $81.95 | 2022 | |
| Glaxosmithkline, LLC. | $77.99 | 2020-2021 | |
| Amgen INC. | $76.83 | 2021-2022 | |
| Lilly USA, LLC | $41.11 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.10 | 2022 | |
| Globus Medical, INC. | $28.91 | 2025 | Senza |
| Abbvie INC. | $26.87 | 2023 | Ubrelvy, Qulipta |
| Philips North America LLC | $25.59 | 2020 | |
| Exact Sciences Corporation | $22.84 | 2023 | Cologuard Collection Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.70 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.25 | 2022 | |
| Organogenesis INC. | $19.77 | 2019-2021 | |
| Hologic Sales and Service, LLC | $19.66 | 2019 | |
| Osiris Therapeutics INC. | $17.08 | 2019 | |
| Kci USA, INC. | $15.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bohlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.